EUROPE BIOSURGERY MARKET FORECAST 2021-2028

EUROPE BIOSURGERY MARKET FORECAST 2021-2028

  • June 2021 •
  • 158 pages •
  • Report ID: 5371573 •
  • Format: PDF
KEY FINDINGS
The Europe biosurgery market is predicted to record a CAGR of 6.16% during the forecasted years of 2021 to 2028. Factors such as the growing burden of chronic conditions likely to cause physical disability, the increasing adoption of new and advanced surgical products, as well as the rising number of surgeries are set to fuel the regional market’s growth.

MARKET INSIGHTS
The Europe biosurgery market growth assessment includes the analysis of Germany, Poland, Italy, Belgium, France, the United Kingdom, Russia, and the rest of Europe.Biosurgery products observe a high demand in Germany on account of their user-friendliness, high efficiency, and affordability.

In this regard, products that facilitate faster healing and prevent scarring are set to record a growing trend in the country. Moreover, as per the ISAPS report, a total number of 647,188 non-surgical-procedures and 336,244 surgical procedures were performed in 2019, with the most common procedures being breast reduction, breast augmentation, and liposuction.
Rheumatoid arthritis is the most extensive form of autoimmune chronic inflammatory arthritis and affects up to 1% of the global population.In Italy, the condition impacts over 300,000 individuals of all ages.

Besides, rheumatoid arthritis is more prevalent in females between 40 and 60.As a result, the increasing cases of the disease play a vital role in propelling the market demand.

Furthermore, according to the World Population Ageing report, 23% of the country’s population was aged 65 years and above in 2019.This number is estimated to reach 36% by 2050, thereby fueling the need for surgeries associated with chronic conditions.

Hence, these factors are set to propel the market growth in Europe during the forecast period.

COMPETITIVE INSIGHTS
Some of the key companies operating in the market are B Braun Melsungen AG, Medtronic PLC, Sanofi, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. BAXTER INTERNATIONAL INC
2. B BRAUN MELSUNGEN AG
3. BECTON, DICKINSON AND COMPANY (C R BARD)
4. BETATECH MEDICAL
5. CSL LIMITED
6. CRYOLIFE INC
7. ETHICON INC (JOHNSON & JOHNSON)
8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9. MEDTRONIC PLC
10. RTI SURGICAL
11. SANOFI
12. SMITH & NEPHEW PLC
13. STRYKER CORPORATION
14. WRIGHT MEDICAL GROUP NV
15. ZIMMER BIOMET HOLDINGS INC